3188 results for «819»
3188 results
Challenging STEMI cases: unwanted situations
21 May 2025 – From EuroPCR 2025
Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.
Wireless physiology assessment
22 May 2025 – From EuroPCR 2025
This session examines the evolving field of wireless physiology assessment in PCI. Topics include randomized trials comparing angiography and physiology guidance, prognostic performance of imaging-derived physiology, and outcomes in various patient subsets including elderly patients with multivessel disease.
Beyond angiography: imaging-guided solutions for stent failure
22 May 2025 – From EuroPCR 2025
Stent failure remains a critical challenge in interventional cardiology — but intracoronary imaging can change the outcome. This session goes beyond angiography to examine why stents fail, how to detect underlying causes, and how imaging-guided strategies can help tailor reintervention. Two real-life cases, from complex restenosis...
How to treat - DCB
21 May 2025 – From EuroPCR 2025
Explore drug-coated balloon (DCB) therapy through detailed case studies covering calcified vessels, small diffuse vessel disease, and de novo ostial lesions. Gain practical insights on treatment approaches and key learning points to enhance your DCB practice.
Calcium modification: contemporary comparaisons of atherectomy and IVL
22 May 2025 – From EuroPCR 2025
Compare contemporary calcium modification techniques including atherectomy and intravascular lithotripsy (IVL) in complex coronary lesions. Review clinical outcomes, procedural case studies, and registry data highlighting safety and efficacy in acute coronary syndrome and high-risk patients.
Vesalio announces FDA Approval of the NeVa VS™ to treat cerebral vasospasm after aneurysmal rupture
15 Sep 2022
Foldax announces positive one-year data on TRIA Mitral Valve
27 Jun 2025
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
